• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMÉRIEUX, SA VITEK MS IND CHCA (MATRIX)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMÉRIEUX, SA VITEK MS IND CHCA (MATRIX) Back to Search Results
Model Number 417067
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Type  malfunction  
Event Description
Intended use: vitek® ms is a mass spectrometry system using matrix-assisted laser desorption/ionization time of flight mass spectrometry (maldi-tof ms) for the identification of microorganisms cultured from human specimens.The vitek® ms system is a qualitative in vitro diagnostic device indicated for use in conjunction with other clinical and laboratory findings to aid in the diagnosis of bacterial, yeast and mould infections.The vitek® ms system is intended for laboratory use by healthcare professionals who are trained in microbiology and good laboratory practices.Issue description: a customer in (b)(6) reported to biomérieux that they have obtained a potential misidentification of klebsiella oxytoca atcc® 700324¿ as raoultella ornithinolytica with the product vitek ms ind chca (matrix) (ref.417067) associated with the equipment vitek ms instrument (ref.410895, serial number (b)(4)).It was reported that the customer performed identification using atcc 700324 bacteria for internal evaluation of vitek ms, and the results were as follows: atcc 700324: klebsiella oxytoca (expected result), vitek ms : raoultella ornithinolytica 99.9%, repeat: no progress.Plate culture conditions were as follows: using 2nd subcultured plate from stock, blood agar ppm plate (local media brand, asan), 35c, 24h, 11/9 cultured.This plate has been stored and has been ordered for sequencing (16s rrna) and will be attached to this case as soon as the results are available.Since a failure occurred during the process of using this atcc 700324 strain as one of the internal evaluation bacteria, the customer also requested a confirmation as to whether it is difficult for vitek ms to identify this strain in routine.As there is no patient associated with this atcc strain, there is no adverse event related to any patient's state of health.An investigation has been initiated.
 
Manufacturer Narrative
A customer in the republic of korea reported to biomérieux that they have obtained a potential misidentification of klebsiella oxytoca atcc® 700324¿ as raoultella ornithinolytica with the product vitek® ms ind chca (matrix) (ref.417067) associated with the equipment vitek ms instrument (ref.410895, serial number (b)(6)).There were no patient or operator death, no patient or operator harmed, no indirect harm patient reported, no patient harmed/treated incorrectly.Fine tuning: status appeared good at the time of acquisition.Spot preparation quality: the sample ¿all peaks¿ values seems to be good (90 peaks).Knowledge base (kb) review: as the customer tested a known collection strain klebsiella oxytoca atcc 700324, the expected identification should be klebsiella oxytoca.However, the strain was identified as raoultella ornithinolytica by 16s sequencing and vitek ms.Both organisms are present in the vitek ms kb v3.2 knowledge base.Sample data analysis: according to data provided, the potential misidentification result was obtained from spectra having a good number of peaks (90).In addition, the potential misidentification was obtained with a good identification score (0.47).The quality of spectra seems to be good.To verify the performance of vitek ms system, two samples of atcc 700324 strains from biomérieux collection strains were tested with vitek ms v3.2.Four spots were performed for each sample.R&d lab mzml files were reprocessed with vitek ms kb v3.2 and the four spectra for each sample led to a single choice as klebsiella oxytoca.Biomérieux r&d laboratory didn¿t reproduce the vitek ms customer results as raoultella ornithinolytica.Both samples of atcc 700324 internal strains were correctly identified by the system.Based on these findings, the source of the customer stock and the quality of the strain will be questioned.Conclusion based on the data above, biomérieux recommended the customer double check the strain.As the spot preparation and fine tuning appeared good, and both organisms are included in the knowledge base, the quality control strain may have become contaminated.Sequencing of the sample showed both organisms to be present, thus there is no evidence at this time that the vitek ms instrument malfunctioned.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VITEK MS IND CHCA (MATRIX)
Type of Device
VITEK MS IND CHCA (MATRIX)
Manufacturer (Section D)
BIOMÉRIEUX, SA
3 route de port michaud
la balme 38390
FR  38390
Manufacturer (Section G)
BIOMÉRIEUX SA
3 route de port michaud
la balme 38390
FR   38390
Manufacturer Contact
jeff scanlan
595 anglum road
hazelwood, MO 63042
MDR Report Key12960335
MDR Text Key288043595
Report Number9615754-2021-00293
Device Sequence Number1
Product Code QBN
Combination Product (y/n)N
Reporter Country CodeKS
PMA/PMN Number
K181412
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 01/10/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number417067
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/10/2021
Initial Date FDA Received12/08/2021
Supplement Dates Manufacturer Received12/13/2021
Supplement Dates FDA Received01/10/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage A
Patient Sequence Number1
-
-